OPINION: drug firms say no to rebates, despite billions in new revenue from Part D

By Wendell Potter

Part D brought drug companies billions, but they say the sky is falling

Drug lobby donation went to pro-Democratic nonprofit

By Michael Beckel

Half-million-dollar donation from PhRMA went to little-known group that backed Harry Reid.

Excerpts from this story referencing "Bob Casey":

"… Commission for telephone calls supporting President Barack Obama and Sen. Bob Casey, D-Pa., in October.When the Center for Public Integrity called the D.C. of …"

Federal regulators have failed to act on toxic chemical, report says

By Chris Hamby

Regulators have done little to protect the public from BPA, critics say

Report faults Medicare controls on widely abused drugs

By Joe Eaton

Beneficiaries easily went to multiple doctors for hydrocodone and oxycodone

Inspectors struggle to keep up with flood of imports

By Brad Racino

Food imports approved for use in the U.S. in an unexpected way

Excerpts from this story referencing "Office of Regulatory Affairs":

"… s year and even less — only 1.47 percent — next year, according to its Office of Regulatory Affairs.This summer, the FDA gave News21 unusual access behind the scenes of its l …"

"… ization,” the report states.Carl Nielsen, former director of the FDA’s Office of Regulatory Affairs Division of Import Operations and Policy, said the biggest problem the FDA …"

Investigations Around the World

By Simona Raetz

Drug on wars makes pain killers unavailable for patients in developing countries; mining companies are big winners of Chilean tax system

FDA's flimsy recall power for food imports puts public at risk, watchdog says

By Aaron Mehta and Ben Wieder

FDA needs more power to police recalls of imported foods

FDA screening of fish imports not catching antibiotics and drug residue

By Laurel Adams

FDA taken to task for sloppy inspections of imported fish

During Mitch Daniels’ decade at Eli Lilly, the drug giant paid billions in fines and settled thousands of lawsuits

By Joanne Kenen and Rochelle Sharpe

Eli Lilly paid billions in fines, settled thousands of lawsuits while Daniels was an executive at the drug giant

Excerpts from this story referencing "CEO":

"… sitions in both the private and public sectors,” it says. “His work as CEO of the Hudson Institute and president of Eli Lilly and Company's North Ame …"

Medicare can’t identify top prescribers of addictive drugs

By The Center for Public Integrity and Joe Eaton

Medicare doesn't know if all the prescriptions it is paying for are being written by real doctors, says a new inspector general's report....

Excerpts from this story referencing "New Jersey":

"… Medco Health Solutions, a Medicare Part D sponsor based in Franklin Lakes, New Jersey that runs the country’s largest mail order pharmacy operation.Contacted …"

FDA criticized for accepting free help from company that later won generic OK

By Laurel Adams

The Food and Drug Administration last month issued guidelines for agency staff to follow when drugmakers offer free help during emergencies

In health, like everything else, men and women really are different

By Amy Biegelsen

Health studies still do not adequately root out differences between men and women, according to a new report from the National Academy of Sc

Most drug trial results analyzed by FDA hidden from view

By Naseem Miller

Before a new drug finds its place on pharmacy shelves or a new device lands in the hands of a surgeon, it goes through a long and complex ap

Excerpts from this story referencing "U.S. Food and Drug Administration":

"… s of a surgeon, it goes through a long and complex approval process by the U.S. Food and Drug Administration.A new drug, for instance, goes through laboratory testing and animal studi …"

"… ion about clinical trials, including results, available to the public. The U.S. Food and Drug Administration Amendments Act of 2007, which went into effect in September 2008, requires …"

"… linical trials data and results for new drugs, biologics and devicesWhere: U.S. Food and Drug AdministrationAvailability: Sporadic, not centralized, and mostly inaccessibleFormat: N/A …"

FDA lags USDA in accessible food safety data

By Jim Morris

Recent outbreaks of food-borne illness left American consumers on edge — and largely in the dark about federal enforcement. The Food and Dru

FDA reaches agreement with firm that produced troubled heart drug

The U.S. Food and Drug Administration last week announced a little-noticed tentative agreement setting conditions under which a troubled pha

Did the FDA miss signals on a troubled heart drug?

By Jeanne Lenzer

It has been a rough eight months for the drug maker Actavis, Inc. and its powerful heart drug, Digitek. Following repeated Food and Drug Adm

FDA enforcement actions way down

By The Center for Public Integrity

Enforcement actions by the (FDA) markedly declined under the Bush administration

Lack of adequate foreign drug oversight

By The Center for Public Integrity

The GAO called for improvement in the FDA’s Foreign Drug Inspection Program in 1998. A decade later, there's been little improvement.

FDA failure to ensure drug safety

By The Center for Public Integrity

Vioxx dangers raise questions about FDA's ability to monitor drugs

More big money from pharmaceutical lobby in 2008

By Mary Beth Lombardo

The economy may be sliding, but that hasn’t stemmed the high-rolling habits of Washington’s largest lobby. In 2007, as the Center recently r

A record year for the pharmaceutical lobby in '07

By M. Asif Ismail

Washington's largest lobby racks up another banner year on Capitol Hill

Spending on lobbying thrives

By M. Asif Ismail

Drug and health products industries invest $182 million to influence legislation

Excerpts from this story referencing "Medicare":

"… kers that drew heavy drug industry lobbying was to undo a provision of the Medicare Prescription Drug, Improvement and Modernization Act of 2003. The legislat …"

"… g blitz, guarantees that the nation's seniors and the disabled who receive Medicare are eligible for some form of prescription drug benefit starting in Januar …"

"… he federal government from negotiating on prices of drugs supplied through Medicare. Many other bulk purchasers, including private insurers and federal depart …"

"… e Secretary of Health and Human Services to negotiate for lower prices for Medicare prescription drugs. A spokeswoman for Wu said the bill never made it out o …"

PEPFAR policy hinders treatment in generic terms

By M. Asif Ismail

Critics say FDA approval rule has meant greater use of high-cost drugs at expense of helping fewer patients

Excerpts from this story referencing "HIV":

"… s (ARVs), which improve the health and extend the lives of people who have HIV/AIDS, had dropped "from $12,000 a year to under $300 a year."That signific …"

"… . In addition to providing the drugs, it typically includes things such as HIV testing, counseling, monitoring for side-effects, lab tests and hospitaliz …"

"… ith AIDSGeneric antiretroviral drugs play a huge role in the fight against HIV, especially in the developing world. Before the rise of generics, ARVs — …"

"… nerics in place of brand-name drugs, it could treat 10 times the number of HIV-infected patients that now receive treatment. PEPFAR's own study this year …"

Drug makers' dime funds Congressional travel

By Robert Brodsky

Pharmaceutical companies, affiliated trade groups spent more than $600,000 on trips

Excerpts from this story referencing "John Breaux":

"… t reliable allies of the pharmaceutical industry in Congress was then-Sen. John Breaux of Louisiana. During his nearly two decades in the Senate, Breaux develope …"

Deep pockets contribute to success

By M. Asif Ismail

Industry spends millions on state campaign donations, Calif. fight

States see importation as solution to high drug costs

By Victoria Kreha

Several seek, have plans despite federal and industry opposition

FDA staff travels on drug industry dollars

By Alexander Cohen

Groups tied to FDA-regulated industry paying for agency officials' trips

Excerpts from this story referencing "New York":

"… s having been sponsored by a third party. On Feb. 21, 2002, he traveled to New York to address the DIA on the subject "Marketing of Pharmaceuticals: How to be …"

Drug lobby second to none

By M. Asif Ismail

How the pharmaceutical industry gets its way in Washington

Excerpts from this story referencing "U.S. House of Representatives":

"… luding more than 15 former Senators and more than 60 former members of the U.S. House of Representatives. The two trade groups, PhRMA and BIO, are headed by two influential former …"

Surrogates for their agenda

By Alexander Cohen

How the drug industry uses non-profits to push its interests

Checkbook politics

By Victoria Kreha

Over the last seven years, the pharmaceutical industry has given $150 million in campaign contributions

Excerpts from this story referencing "Federal Election Commission":

"… e organizations, which register with the Internal Revenue Service, not the Federal Election Commission, played a huge role in the last election, with both Republican-leaning and …"